Italy· 035679036
CHINOPLUS*5 cpr rivestite 600 mg
A medicinal product containing prulifloxacina, registered in Italy by SPA (SOC.PRO.ANTIBIOTICI) SpA, on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Prulifloxacina
- Manufacturer
- SPA (SOC.PRO.ANTIBIOTICI) SpA
- Country
- Italy (IT)
- ATC code
- —
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic035679036CHINOPLUS*5 cpr rivestite 600 mgEUR 19.54
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Prulifloxacina in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Greece · Glimbax, Prixina
- Portugal · Oliflox, Unidrox
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/31532c34-7ab8-4b65-9c5d-be2ecf349d81 GET /v1/drugs/31532c34-7ab8-4b65-9c5d-be2ecf349d81?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 19.54,
"source": "aifa",
"currency": "EUR",
"strength": "PRULIFLOXACINA 600MG 5 UNITA' USO ORALE",
"substance": "Prulifloxacina",
"equivalence_group": "R1A",
"transparency_flag": null
}See everything about prulifloxacina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.